Mine Hayriye SORGUN, Canan YÜCESAN, Yasemin GENÇ

Headache in multiple sclerosis

Although multiple sclerosis (MS) can cause almost any neurological symptom, headaches are considered unusual. Studies investigating the relationship between the 2 conditions have produced conflicting results. The primary aim of this study was to test whether there was a difference between patients with MS (Group 1) and the control group (Group 2, patients with psoriasis and myasthenia gravis, diseases not affecting the central nervous system) in terms of the prevalence and types of primary headache. Materials and methods: A total of 139 patients with MS and 59 patients in the control group were included. The patients underwent a complete neurological examination and functional systems were assessed according to the functional system scores of Kurtzke. A semistructured interview guided by a questionnaire about headache was applied. Results: We found the life-long prevalence of primary headaches as 74.8% in patients with MS and as 71.2% in the control group. The prevalence of migraine and tension-type headaches did not show a significant difference between the 2 groups before the disease (P = 0.43), after the onset of disease (P = 0.18), or during the attack (P = 0.097). Conclusion: MS does not increase the prevalence of headaches, and headache types do not show any difference between MS patients and the control group.

Anahtar Kelimeler:

Key words: Multiple sclerosis, headache, prevalence, migraine, tension-type headache

Headache in multiple sclerosis

Keywords:

Key words: Multiple sclerosis, headache, prevalence, migraine, tension-type headache,

PDF

___

Kister I, Caminero AB, Monteith TS, Soliman A, Bacon TE, Bacon JH, Kalina JT, Inglese M, Herbert J, Lipton RB. Migraine is comorbid with multiple sclerosis and associated with a more symptomatic MS course. J Headache Pain 2010; 11: 417–425.
Editorial. Headache in multiple sclerosis. Brit Med J 1969; 1: 713–714.
Villani V, Prosperini L, Ciuffoli A, Pizzolato R, Savletti M, Sette G. Primary headache and multiple sclerosis: preliminary results of prospective study. Neurol Sci 2008; 29: 146–148.
Sandyk R, Awerbuch GI. The co-occurrence of multiple sclerosis and migraine headache: the serotoninergic link. Int J Neurosci 1994; 76: 249–257.
Haas DC, Kent PF, Friedman DI. Headache caused by a single lesion of multiple sclerosis in the periaqueductal gray area. Headache 1993; 33: 452–455.
Rolak LA, Brown S. Headaches and multiple sclerosis: a clinical study and review of the literature. Neurology 1990; 237: 300– 302.
Gee JR, Chang J, Dubli AB, Vijayan N. The association of brainstem lesions with migraine-like headache: an imaging study of multiple sclerosis. Headache 2005; 45: 670–677.
Galer BS, Lipton RB, Weinstein S, Bello L, Solomon S. Apoplectic headache and oculomotor palsy: an unusual presentation of multiple sclerosis. Neurology 1990; 40: 1465– 1466.
Leandri M, Cruccu G, Gottlieb A. Cluster headache-like pain in multiple sclerosis. Cephalagia 1999; 19: 732–734.
Gentille S, Ferrero M, Vaula G, Rainero I, Pinessi L. Cluster headache attacks and multiple sclerosis. J Headache Pain 2007; 8: 245–247.
Alstadhaug K, Breivik K, Rusic Z. Recurrent headache due to MS plaque. Headache 2008; 48: 453–454.
Fragoso YD, Brooks JB. Two cases of lesions in brainstem in multiple sclerosis and refractory migraine. Headache 2007; 47: 852–854.
Liu FC, Fuh JL, Wang SJ. Symptomatic trigeminal autonomic cephalalgia associated with allodynia in a patient with multiple sclerosis. J Chin Med Assoc 2008; 71: 583–586.
Polmann W, Erasmus LP, Feneberg W, Bergh FT, Straube A. Interferon beta but not glatiramer acetate therapy aggravates headaches in MS. Neurology 2002; 24: 605–607.
Boneschi FM, Colombo B, Annovazzi P, Martinelli V, Bernasconi L, Solaro C, Comi G. Lifetime and actual prevalence of any type of pain and headache in multiple sclerosis. Mult Scler 2008; 14: 514–521.
La Mantia L, D’Amico D, Rigamonti A, Mascoli N, Bussone G, Milanese C. Interferon treatment may trigger primary headaches in multiple sclerosis patients. Mult Scler 2006; 12: 476–480.
Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders 2nd Edition. Cephalalgia 2004; 24; 9–160.
Fischer JS, Foley FW, Aikens JE, Ericson GD, Rao SM, Schindell SS. What do we really know about cognitive dysfunction, affective disorders, and stress in multiple sclerosis? A practitioner’s guide. J Neurol Rehabil 1994; 8: 151–164.
Silberstein SD, Lipton RB, Goadsby P. Headache in Clinical Practice. 2nd ed. London: Martin Dunitz, 2002.
Empl M, Straube A. The immune system and primary headache syndromes. Anaesthesist 2001; 50 :7 83–91.
Gülekon A. Psoriasis ve benzeri dermatozlar. In: Tüzün Y, Gürer MA, Serdaroğlu S, Oğuz O, Aksunan VL, editors. Dermatoloji. 3rd ed. İstanbul: Nobel Tıp Kitabevleri; 2008. pp. 758–759.
Hillert J. Human leucocyte antigen studies in multiple sclerosis. Ann Neurol 1994; 36: 15–17.
Björn R. HLA and prognosis in MS. J Neurol 1994; 241: 385– 390.
Tsujisaki M, Hirata H. Detection of circulating ICAM-1 antigen in malignant diseases. Clin Exp Immunol 1991; 85: 3–8.
Seth R, Raymond FD. Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet 1991; 338: 83–84.
Lassmann H, Brück W, Lucchinetti CF. The immunopathology of multiple sclerosis: an overview. Brain Pathol 2007; 17: 210– 218.
Korn T. Pathophysiology of multiple sclerosis. J Neurol 2008; 255: 2–6.
Loffredo S, Ayala F, Marone G, Delfino G, Stranges S, Marone G. Immunopathogenesis of psoriasis and pharmacological perspectives. J Rheumatol Suppl 2009; 83: 9–11.